Category | Overall population n = 95 pts | A: Patients < 70 years n = 75 pts | B: Patients ≥70 years n = 20 pts | P-value “patients < 70 years” versus “patients ≥70 years” |
---|---|---|---|---|
Patient age [years] (range) | 53.2 ± 16.1 (17–76) | 48 ± 13.6 (17–69) | 73 ± 2.0 (70–76) | – |
Gender (%): | ||||
• Male (%) | 36 (38) | 29 (39) | 7 (35) | 0.764* |
• Female (%) | 59 (62) | 46 (61) | 13 (65) | |
BMI [kg/m2] (range) | 27.5 ± 5.4 (16.2–43.2) | 27.5 ± 5.6 (16.2–43.2) | 27.3 ± 4.4 (19.3–36.2) | 0.872** |
ASA score (%): | ||||
• ASA 1 (%) | 6 (6) | 5 (7) | 1 (5) | Lack of items. |
• ASA 2 (%) | 64 (67) | 51 (68) | 13 (65) | |
• ASA 3 (%) | 25 (26) | 19 (25) | 6 (30) | |
CCI score (range) | 0.47 ± 0.766 (0–3) | 0.45 ± 0.776 (0–3) | 0.55 ± 0.759 (0–3) | 0.620** |
Diabetes mellitus (%) | 9 (9.4) | 7 (9.3) | 2 (10) | Lack of items. |
ISAR score (%): | ||||
• ISAR score 0 | 45 (47) | 39 (52) | 6 (30) | Lack of items. |
• ISAR score 1 | 38 (40) | 28 (37) | 10 (50) | |
• ISAR score 2 | 8 (8) | 6 (8) | 2 (10) | |
• ISAR score 3 | 4 (4) | 2 (3) | 2 (10) | |
Cause of bladder function disorder (%): | ||||
• OAB (%) | 48 (51) | 35 (47) | 13 (65) | 0.145* |
• Retention (%) | 47 (49) | 40 (53) | 7 (35) | |
OAB classification (%): | ||||
• OAB dry (%) | 16 (33) | 11 (31) | 5 (39) | 0.645* |
• OAB wet (%) | 32 (67) | 24 (69) | 8 (61) | |
Prior OAB therapy (%): | ||||
• Oral medication (%) | 48 (48/48, 100) | 35 (35/35, 100) | 13 (13/13, 100) | 0.249*# |
• Onabotulinumtoxin A (%) | 23 (23/48, 48) | 15 (15/35, 43) | 8 (8/13, 62) | |
Prior retention therapy (%): | ||||
Oral medication (%) | 8 (8/47, 17) | 8 (8/40, 20) | 0 | Lack of items. |
Catheterization (%) | 39 (39/47, 83) | 32 (32/40, 80) | 7 (7/7, 100) |